On 17th February 2020 the RESTORE Momentum Workshop will take place in Berlin and will welcome RESTORE supporters and partners. TEDDY Network is involved in RESTORE as supporter, a large-scale Research Initiative with the scope to create a consortium aimed to build a coordinated, financially strong, academia-industry partnership in order to tackle the main interdisciplinary
SiS.net3, the International network of National Contact Points in the field of Science with and for Society in Horizon 2020 are organising the brokerage event on 17th-19th March, 2020 in Brussels. The event will be of particular interest and relevance to members of the research community who are looking for networking and funding opportunities within
On 15 January 2020, the EFGCP & EFPIA Workshop "Roadmap Initiative to Good Lay Summary Practices” will be held in Brussels. The upcoming Clinical Trial Regulation requires the development and dissemination of Lay Summaries of clinical study results from commercial and non-commercial sponsors. EMA has released an Expert Group Recommendation on the content of Lay
On November 25th, 2019, the Food and Drug Administration (FDA) granted accelerated approval to voxelotor (Oxbryta, Global Blood Therapeutics) for adults and paediatric patients 12 years of age older with sickle cell disease (SCD). SCD is a lifelong inherited blood disorder caused by a genetic mutation in the beta-chain of haemoglobin (HbS). Mutated HbS has
Over the last months, a worrying shortage in the production and distribution of vincristine has affected the health marketplace across the world. Vincristine is an antineoplastic drug, a natural extract from the periwinkle (Cantharanthus roseus, formerly Vinca rosea), which is a species of myrtle. Vincristine is an antitumor drug hugely used in the care of
We are happy to announce that even this year the youths of KIDS Bari and KIDS Albania have kicked off their activities aimed to promote the involvement of young persons and patients in the research and clinical fields strongly favouring the achievement of goals in the paediatric drug development and availability. The healthy youths and
On 19th and 20th November 2019, the Annual meeting “Clinical Trials Europe” was held in Barcelona and provided the occasion to bring the clinical community together. The participants had the possibility to share and discuss fresh perspectives and practises for clinical management, patient centricity, drug development operating environment and digital revolution. TEDDY Network participated in
Ensuring high-quality ethical research on the safety and efficacy of medicines for children represents one of the main objectives of the paediatric sector! However, there are no summary data in the public domain about the capacity and competence of European paediatric centres to carry out research studies. To this end, the TEDDY Network developed and
On 24 October 2019, EUCROF Paediatric Working Group organised a F2F training on “Essentials of paediatric clinical research” held at the Centro Nacional de Invesigaciones Oncológicas in Madrid. The meeting provided the occasion to give an overview of the current regulatory landscape for paediatric research, review specific and most important challenges with corresponding solutions in
On 21 and 22 October 2019, the 4th EPTRI General Assembly Meeting will be held in Warsaw and will be organised in collaboration with the Polish partner, the Children’s Memorial Health Institute. EPTRI (European Paediatric Translational Research Infrastructure) is aimed to design a new paediatric Research Infrastructure, intended to accelerate paediatric drug development including most